India’s stock brokerage industry is undergoing a structural transformation as retail participation surges. While industry ...
TLX591-CDx (Illuccix® in approved jurisdictions, 68Ga-PSMA-11): Positive data from Phase 3 study in Chinese patients provides the basis for near-term NDA submission in China.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback